Asymmetric dimethylarginine in the maternal and fetal circulation in preeclampsia. (Q45937731)

18 December 2017

title

Asymmetric dimethylarginine in the maternal and fetal circulation in preeclampsia. (English)

1 reference

18 December 2017

persistent fetal circulation syndrome

main subject

pre-eclampsia

0 references

1 reference

Per M Ueland

1 reference

18 December 2017

Anne Cathrine Staff

1 reference

18 December 2017

Kristin Braekke

series ordinal

object named as

Kristin Braekke

1 reference

18 December 2017

author name string

Nina K Harsem

series ordinal

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

18 December 2017

published in

Pediatric Research

1 reference

18 December 2017

volume

1 reference

18 December 2017

issue

1 reference

18 December 2017

page(s)

411-415

1 reference

18 December 2017

Homocysteine, cysteine, and related metabolites in maternal and fetal plasma in preeclampsia

cites work

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Blood pressure, serum lipids, fasting insulin, and adrenal hormones in 12-year-old children born with maternal preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Intrauterine exposure to preeclampsia and adolescent blood pressure, body size, and age at menarche in female offspring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Mechanisms underlying developmental programming of elevated blood pressure and vascular dysfunction: evidence from human studies and experimental animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Reduced L-arginine level and decreased placental eNOS activity in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Plasma concentrations of asymmetric dimethylarginine (ADMA) in Colombian women with pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Determination of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, in umbilical blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

ACOG technology assessment. Genetics and molecular diagnostic testing. Number 1, July 2002. American College of Obstetrics and Gynecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Longitudinal reference ranges for estimated fetal weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Quantitative profiling of folate and one-carbon metabolism in large-scale epidemiological studies by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

The clinical significance of asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

The glomerular injury of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Levels of dimethylarginines and cytokines in mild and severe preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Maternal and fetal amino acid concentrations and fetal outcomes during pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Concentrations of homocysteine, related metabolites and asymmetric dimethylarginine in preeclamptic women with poor nutritional status

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Subtle changes in ADMA and l-arginine concentrations in normal pregnancies are unlikely to account for pregnancy-related increased flow-mediated dilatation

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

Preventing pregnancy-induced hypertension: are there regional differences for this global problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B33392

10.1203/PDR.0B013E3181B33392

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

Dimensions Publication ID

1015398326

0 references

1 reference

18 December 2017